PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 35 filers reported holding PSYCHEMEDICS CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $249,000 | +2.9% | 40,221 | -15.3% | 0.00% | – |
| Q4 2020 | $242,000 | +15.8% | 47,487 | 0.0% | 0.00% | – |
| Q3 2020 | $209,000 | -19.9% | 47,487 | 0.0% | 0.00% | – |
| Q2 2020 | $261,000 | -9.1% | 47,487 | 0.0% | 0.00% | – |
| Q1 2020 | $287,000 | -34.9% | 47,487 | -1.4% | 0.00% | – |
| Q4 2019 | $441,000 | +0.5% | 48,160 | 0.0% | 0.00% | – |
| Q3 2019 | $439,000 | -9.7% | 48,160 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $486,000 | -28.1% | 48,160 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $676,000 | -11.5% | 48,160 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $764,000 | -15.7% | 48,160 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $906,000 | -2.3% | 48,160 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $927,000 | -6.9% | 48,160 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $996,000 | +0.6% | 48,160 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $990,000 | +11.5% | 48,160 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $888,000 | -26.1% | 48,160 | 0.0% | 0.00% | -50.0% |
| Q2 2017 | $1,202,000 | +24.4% | 48,160 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $966,000 | -18.8% | 48,160 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,189,000 | +24.4% | 48,160 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $956,000 | +44.4% | 48,160 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $662,000 | 0.0% | 48,160 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $662,000 | +35.7% | 48,160 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $488,000 | +0.6% | 48,160 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $485,000 | -32.1% | 48,160 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $714,000 | 0.0% | 48,160 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $714,000 | 0.0% | 48,160 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $714,000 | +4.2% | 48,160 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $685,000 | +0.4% | 48,160 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $682,000 | -10.0% | 48,160 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $758,000 | +8.3% | 48,160 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $700,000 | +9.7% | 48,160 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $638,000 | +23.4% | 48,160 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $517,000 | – | 48,160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 40,001 | $276,000 | 0.13% |
| SANTA MONICA PARTNERS LP | 20,000 | $138,000 | 0.10% |
| Invenomic Capital Management LP | 135,631 | $769,000 | 0.08% |
| Cannell Capital | 78,306 | $540,000 | 0.08% |
| RBF Capital, LLC | 144,231 | $996,000 | 0.06% |
| CRAWFORD INVESTMENT COUNSEL INC | 266,502 | $1,839,000 | 0.04% |
| Ancora Advisors LLC | 80,728 | $557,000 | 0.01% |
| HighMark Wealth Management LLC | 2,039 | $14,000 | 0.01% |
| Renaissance Technologies | 341,422 | $2,356,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 34,618 | $240,000 | 0.00% |